Three big bank names have taken three wildly different paths through 2026, and the gap between the winner and the loser comes down to a business model difference that most investors overlook when picking…
One large-cap drugmaker has quietly lapped its peers in 2026 without a single obesity drug in its lineup, while the companies chasing the hottest trend in pharma are fighting for second place and last.
Three industrial giants all chased the same AI power buildout in 2026, but the market rewarded them very differently, and the gap between winner and also-ran reveals exactly what investors are betting on next.
An economist is calling the current U.S. industrial expansion the largest in the nation's history, projecting staggering investment figures that dwarf anything seen in the steel and auto eras. But the data behind the…
An 88-year-old shoe store owner has collected Social Security for over two decades while still climbing ladders and fitting customers, but hitting his retirement milestone only cancelled one of his obligations to the program,…
Mortgage rates pushing toward 7% sent builders scrambling to cut production before buyers vanish entirely, but the real question is whether that panic creates an opening for households willing to act while others freeze.
Live Updates Webull Q2 Earnings Coverage Wrap-Up4:31pm ETThat wraps up our initial coverage of Webull’s Q2 results. Thank you for stopping by! Pattern Day Trader Rule Removal Is Already Supercharging Webull4:30pm ETWebull said the…
Tempus AI wrote a $1.5 billion check for a genomics company most investors had never heard of, and one blockbuster clinical trial announcement just changed everything about how that deal looks.
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
A top equity strategist is steering clients away from the S&P 500, and the reasoning goes deeper than simple valuation math. The real story is a balance-sheet wound that quietly healed while most investors…
A former lobsterman trades traps for a deli counter, leaves every dollar of profit inside the business, and still watches Social Security start withholding his checks. What he missed about partnership income changes the…
AI infrastructure spending and ballooning federal deficits are colliding in the Treasury market, and the shockwave is now hitting Asian tech stocks hard. The question is whether this is a brief repricing or the…
A $100 million buyback authorization from United States Antimony landed just days after a badly missed quarter and a guidance cut that nearly halved the full-year outlook, raising a pointed question about whether management…
Nelson Peltz is circling Wendy's with a take-private consortium even as the burger chain logs its sixth straight quarter of falling sales and shutters hundreds of restaurants. Whether deal fever or a genuine turnaround…
Treasury Secretary Scott Bessent just made an aggressive move to stop the worst long-end bond selloff in nearly two decades, and whether it works or backfires has direct consequences for your mortgage payment and…
